{
 "ticker": "GDOC",
 "name": "Goldman Sachs Future Health Care Equity ETF",
 "issuer": "Goldman Sachs",
 "desk": "themes",
 "url": "https://etfiq.com/funds/GDOC",
 "html": "https://etfiq.com/funds/GDOC",
 "markdown": "https://etfiq.com/funds/GDOC.md",
 "as_of": "2026-09-11",
 "verdict": "GDOC holds 41 stocks, and 43% of its weight is outside the S&P 500.",
 "key_facts": [
  {
   "key": "already_in_the_s_p_500",
   "label": "Already in the S&P 500",
   "value": "56.7%",
   "source": null,
   "as_of": "2026-09-11",
   "sentence": "GDOC, already in the S&P 500: 56.7%, as of Sep 11, 2026."
  },
  {
   "key": "active_share_vs_the_s_p_500",
   "label": "Active share vs the S&P 500",
   "value": "95.3%",
   "source": null,
   "as_of": "2026-09-11",
   "sentence": "GDOC, active share vs the S&P 500: 95.3%, as of Sep 11, 2026."
  },
  {
   "key": "top_ten_holdings",
   "label": "Top ten holdings",
   "value": "58.2%",
   "source": null,
   "as_of": "2026-09-11",
   "sentence": "GDOC, top ten holdings: 58.2%, as of Sep 11, 2026."
  },
  {
   "key": "total_return_1_year",
   "label": "Total return, 1 year",
   "value": "+10.8%",
   "source": null,
   "as_of": "2026-09-11",
   "sentence": "GDOC, total return, 1 year: +10.8%, as of Sep 11, 2026."
  },
  {
   "key": "net_assets",
   "label": "Net assets",
   "value": "$20m",
   "source": "SEC filing, whole fund, as filed for May 31, 2026",
   "as_of": "2026-09-11",
   "sentence": "GDOC, net assets: $20m (SEC filing, whole fund, as filed for May 31, 2026)."
  },
  {
   "key": "expense_ratio",
   "label": "Expense ratio",
   "value": "0.75%",
   "source": "485BPOS XBRL, Dec 29, 2025",
   "as_of": "2026-09-11",
   "sentence": "GDOC, expense ratio: 0.75% (485BPOS XBRL, Dec 29, 2025)."
  }
 ],
 "fields": [
  {
   "key": "theme",
   "label": "Theme",
   "value": "Broad innovation and megatrends",
   "source": "ETFIQ, editorial"
  },
  {
   "key": "launched",
   "label": "Launched",
   "value": "Nov 11, 2021",
   "source": null
  },
  {
   "key": "already_in_the_s_p_500_by_weight",
   "label": "Already in the S&P 500, by weight",
   "value": "56.7%",
   "source": "ETFIQ"
  },
  {
   "key": "active_share_vs_the_s_p_500",
   "label": "Active share vs the S&P 500",
   "value": "95.3%",
   "source": "ETFIQ"
  },
  {
   "key": "already_in_the_nasdaq_100_by_weight",
   "label": "Already in the Nasdaq-100, by weight",
   "value": "9.4%",
   "source": "ETFIQ"
  },
  {
   "key": "active_share_vs_the_nasdaq_100",
   "label": "Active share vs the Nasdaq-100",
   "value": "98.6%",
   "source": "ETFIQ"
  },
  {
   "key": "top_ten_holdings_weight",
   "label": "Top ten holdings weight",
   "value": "58.2%",
   "source": null
  },
  {
   "key": "holdings",
   "label": "Holdings",
   "value": "41",
   "source": null
  },
  {
   "key": "holdings_as_of",
   "label": "Holdings as of",
   "value": "May 31, 2026",
   "source": "SEC N-PORT"
  },
  {
   "key": "top_holdings",
   "label": "Top holdings",
   "value": "ELI LILLY & COMPANY 13.5%, JOHNSON & JOHNSON 8.2%, MERCK & COMPANY INC 6.0%, GUARDANT HEALTH INC 5.4%, ASTRAZENECA PLC 4.9%, THERMO FISHER SCIENTIFIC INC 4.6%, ARGENX SE 4.1%, INTUITIVE SURGICAL INC 4.0%, BOSTON SCIENTIFIC CORP 3.8%, HOYA CORP 3.6%",
   "source": null
  },
  {
   "key": "net_assets",
   "label": "Net assets",
   "value": "$20m",
   "source": "SEC filing, whole fund, as filed for May 31, 2026"
  },
  {
   "key": "below_its_all_time_high",
   "label": "Below its all-time high",
   "value": "\u22126.3%",
   "source": "ETFIQ"
  },
  {
   "key": "expense_ratio",
   "label": "Expense ratio",
   "value": "0.75%",
   "source": "485BPOS XBRL, Dec 29, 2025"
  },
  {
   "key": "fee_for_the_part_that_differs_from_the_s_p_500_active_expense_ratio",
   "label": "Fee for the part that differs from the S&P 500, active expense ratio",
   "value": "0.79%",
   "source": "ETFIQ"
  },
  {
   "key": "closest_funds_by_holdings_overlap",
   "label": "Closest funds by holdings overlap",
   "value": "PBPH 37%, BMED 31%, FMED 24%, HELX 23%, THNR 22%",
   "source": null
  }
 ],
 "periods": [
  {
   "window": "3 months",
   "Total return": "+8.1%",
   "S&P 500": "+3.3%",
   "Gap to S&P 500": "+4.8 pts",
   "Gap to Nasdaq-100": "+8.9 pts"
  },
  {
   "window": "6 months",
   "Total return": "+12.1%",
   "S&P 500": "+16.0%",
   "Gap to S&P 500": "\u22124.0 pts",
   "Gap to Nasdaq-100": "\u22128.6 pts"
  },
  {
   "window": "1 year",
   "Total return": "+10.8%",
   "S&P 500": "+17.5%",
   "Gap to S&P 500": "\u22126.8 pts",
   "Gap to Nasdaq-100": "\u221212.2 pts"
  },
  {
   "window": "3 years",
   "Total return": "+14.5%",
   "S&P 500": "+77.9%",
   "Gap to S&P 500": "\u221263.4 pts",
   "Gap to Nasdaq-100": "\u221280.6 pts"
  },
  {
   "window": "Since launch",
   "Total return": "\u22126.1%",
   "S&P 500": "+75.8%",
   "Gap to S&P 500": "\u221281.9 pts",
   "Gap to Nasdaq-100": "\u221294.5 pts"
  }
 ],
 "questions": [
  {
   "q": "How much of GDOC is in S&P 500 companies?",
   "a": "By its holdings filed for May 31, 2026, 57% of GDOC by weight is stocks the S&P 500 already holds. Its active share against the index is 95%, so that share is the part doing something different."
  },
  {
   "q": "What does GDOC hold?",
   "a": "41 positions as filed for May 31, 2026, with the top ten at 58% of the fund. The largest are ELI LILLY & COMPANY at 13.5%, JOHNSON & JOHNSON at 8.2%, MERCK & COMPANY INC at 6.0%."
  },
  {
   "q": "Has GDOC beaten the S&P 500?",
   "a": "Over the year to Sep 11, 2026 GDOC returned +10.8% with distributions reinvested, against +17.5% for the S&P 500, so it finished behind the index by 6.8 points."
  },
  {
   "q": "What does GDOC cost?",
   "a": "The prospectus expense ratio is 0.75% a year. Because 95% of the fund differs from the S&P 500, the fee on that differing part works out at 0.79%."
  }
 ],
 "generated": "2026-09-13",
 "license": "Free to use with attribution. ETFIQ (etfiq.com)."
}